Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's disease trial

被引：42

作者：

Schneider, LS ^{[1
]}

Ismail, MS ^{[1
]}

Dagerman, K ^{[1
]}

Davis, S ^{[1
]}

Olin, J ^{[1
]}

McManus, D ^{[1
]}

Pfeiffer, E ^{[1
]}

Ryan, JM ^{[1
]}

Sultzer, DL ^{[1
]}

Tariot, PN ^{[1
]}

机构：

[1] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA

来源：

SCHIZOPHRENIA BULLETIN | 2003年 / 29卷 / 01期

关键词：

Alzheimer's disease; atypical antipsychotic; psychosis; dementia; effectiveness;

D O I：

10.1093/oxfordjournals.schbul.a006991

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

This article describes the development of the protocol for the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Alzheimer's disease trial, which was developed in collaboration with the National Institute of Mental Health to assess the effectiveness of atypical antipsychotics for psychosis and/or agitation occurring in outpatients with Alzheimer's disease. The article provides a detailed description of the methodology used in the trial as well as the clinical outcomes and effectiveness measures incorporated into it, discussing the most salient issues encountered in developing the design of the trial, as well as the unique features of the trial.

引用

页码：57 / 72

页数：16

共 50 条

[21] PET/CT/MRI in Clinical Trials of Alzheimer's Disease
Hoilund-Carlsen, Poul F.
Alavi, Abass
Barrio, Jorge R.
JOURNAL OF ALZHEIMERS DISEASE, 2024, 101 : S579 - S601
[22] Clinical methodology of Alzheimer's disease trials
Gray, JA
DRUG INFORMATION JOURNAL, 1999, 33 (01): : 245 - 252
[23] Psychosis and antipsychotic medications in Alzheimer's disease: Clinical management and research perspectives
Sultzer, DL
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 17 (1-2) : 78 - 90
[24] Clinical Trials and Alzheimer's Disease: A Webliography
Howard, Allison
JOURNAL OF CONSUMER HEALTH ON THE INTERNET, 2014, 18 (01) : 67 - 80
[25] Clinical Methodology of Alzheimer’s Disease Trials
Julian A. Gray
Drug information journal : DIJ / Drug Information Association, 1999, 33 (1): : 245 - 252
[26] Alzheimer's disease failed clinical trials
Asher, Shreya
Priefer, Ronny
LIFE SCIENCES, 2022, 306
[27] Globalization of Alzheimer's disease clinical trials
Cummings, Jeffrey
Reynders, Robert
Zhong, Kate
ALZHEIMERS RESEARCH & THERAPY, 2011, 3 (04)
[28] Promising candidates from drug clinical trials: Implications for clinical treatment of Alzheimer's disease in China
Cao, Yuxia
Yu, Feng
Lyu, Yi
Lu, Xianfu
FRONTIERS IN NEUROLOGY, 2022, 13
[29] The clinical syndrome of Alzheimer's disease: aspects particularly relevant to clinical trials
Mohs, RC
GENES BRAIN AND BEHAVIOR, 2005, 4 (03) : 129 - 133
[30] Statistical analysis, trial design and duration in Alzheimer's disease clinical trials: a review
Thompson, P. A.
Wright, D. E.
Counsell, C. E.
Zajicek, J.
INTERNATIONAL PSYCHOGERIATRICS, 2012, 24 (05) : 689 - 697

← 1 2 3 4 5 →